Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
- PMID: 32265842
- PMCID: PMC7099758
- DOI: 10.3389/fendo.2020.00151
Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
Keywords: assisted reproductive technologies (ART); follicle stimulating hormone (FSH); follitropin delta; human menopausal gonadotrophin (hMG); ovarian stimulation.
Comment on
-
The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.Front Endocrinol (Lausanne). 2019 Jul 3;10:429. doi: 10.3389/fendo.2019.00429. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31333582 Free PMC article. Review.
References
-
- Nyboe Andersen A, Nelson SM, Fauser BCJM, García-Velasco JA, Klein BM, Arce J-C, et al. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial. Fertil Steril. (2017) 107:387–96.e4. 10.1016/j.fertnstert.2016.10.033 - DOI - PubMed
-
- European Medicines Agency Rekovelle: Follitropin Delta. (2017). Available online at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medici... (accessed August 20, 2019).
-
- Therapeutic Goods Administration (TGA) Commonwealth of Australia Australian Public Assessment Report (AusPAR) Rekovelle (2017). Available online at: https://www.tga.gov.au/sites/default/files/auspar-follitropin-delta-rhu-... (accessed March 29, 2019).
Publication types
LinkOut - more resources
Full Text Sources
